@article{oai:shiga-med.repo.nii.ac.jp:00003154,
 author = {高野, 淳 and 住本, 秀敏 and 寺本, 晃治 and 醍醐, 弥太郎},
 issue = {1},
 journal = {滋賀医科大学雑誌},
 month = {Mar},
 note = {Departmental Bulletin Paper, The use of anti-cancer drugs and their combinations are becoming complex, because various new regimens for treating different types of cancer have been developed. As demonstrated by the approval of immune check point inhibitors, the regimens for cancer chemotherapy at Shiga University of Medical Science (SUMS) Hospital are becoming more diverse. In this manuscript, we evaluated the regimens approved by the chemotherapy regimen committee at SUMS Hospital before and after 2014 and discussed the roles of chemotherapy regimen registration system for the appropriate use of new anti-cancer drugs including immune check point inhibitors.},
 pages = {102--107},
 title = {滋賀医科大学医学部附属病院腫瘍センターにおけるがん薬物療法のレジメン審査と適正管理の動向に関する考察},
 volume = {30},
 year = {2017}
}